Interrelation between systemic inflammation markers, endothelial dysfunction and coronary heart disease clinical course after community-acquired pneumonia
DOI:
https://doi.org/10.14739/2310-1237.2015.3.56117Keywords:
Coronary Disease, Pneumonia, C-Reactive Protein, Neopterin, Pregnancy-Associated Plasma Protein-AAbstract
Extensive research has established that community acquired pneumonia has negative impact on clinical course on coronary heart disease (CHD), but the pathogenic mechanism was not understood.
Aim. To study the pro-inflammatory biomarkers and endothelial dysfunction, its interrelation with CHD clinical course in patients with community acquired pneumonia, 90 patients were recruited.
Methods and results. The I (main) subcohort included 60 CHD patients with community acquired pneumonia, the II subcohort included 30 stable angina pectoris without community acquired pneumonia and 21 community acquired pneumonia patients, ІІІ clinical group – without CHD. Using immunoassay high-sensitive C-reactive protein, neopterine and pregnancy-associated protein A were assessed. Among patients with CHD and community acquired pneumonia the significant increasing of all biomarkers was observed at the beginning and after 1 month of disease. The increasing of these biomarkers was associated with was associated with poorer prognosis in CHD patients during 1 year follow-up.
Conclusions. The direct correlation between high-sensitive C-reactive protein and neopterine, РАРР-А was found, which suggests the pathogenic ties between immune inflammation and endothelial dysfunction among patients with CHD and community acquired pneumonia.
References
Kovalenko, V. M. & Kornatskyi, V. M. (2015). Stress i khvoroby systemy krovoobihu. [Stress and cardio-vascular diseases]. Kyiv. [in Ukainian].
Jasti, H., Mortensen, E., Obrosky, D., Kapoor, W. & Fine, M. (2008). Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clinical infectious diseases, 46(4), 550–556. doi: 10.1086/526526.
Matusevych, V., Nedospasova, O., Antonenko, L., Bushura, I., & Nikiforova, L. (2013). Porivnialni dani pro rozpovsiudzhenist khvorob orhaniv dykhannia i medychnu dopomohu khvorym na khvoroby pulmonolohichnoho ta alerholohichnoho profiliu v Ukraini za 2006–2012 rr. [Comparative data on the prevalence of respiratory diseases and medical care for patients with pulmonary and allergic profile in Ukraine for 2006–2012 years]. Yu. Feshchenko (ed.). Kyiv. [in Ukrainian].
Corrales-Medina, V., Musher, D., Wells, G., Chirinos, J., Chen, L. & Fine, M. (2012). Cardiac Complications in Patients With Community-Acquired Pneumonia: Incidence, Timing, Risk Factors, and Association With Short-Term Mortality. Circulation, 125(6), 773–781. doi: 10.1161/CIRCULATIONAHA.111.040766.
Musher, D., Rueda, A., Kaka, A. & Mapara, S. (2007). The association between pneumococcal pneumonia and acute cardiac events. Clinical infectious diseases, 45(2), 158–165.
Ramirez, J., Aliberti, S., Mirsaeidi, M., Peyrani, P., Filardo, G., Amir, A., et al. (2008). Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clinical infectious diseases, 47(2), 182–187. doi: 10.1086/589246.
Chang, C., Mills, G., Karalus, N., Jennings, L., Laing, R., Murdoch, D., et al. (2013). Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults. PloS one, 8(5), 62612. doi: 10.1371/journal.pone.0062612.
Ragino, Yu. I., Chernjavski, A. M., Polonskaya, Ya. V., Volkov, A. M., Kashtanova, E. V., Tcimbal, S. Yu., & Polovnikova, E. M. (2012). Vospalitel'no-destruktivnye biomarkery nestabil'nosti ateroskleroticheskikh blyashek: issledovaniya sosudistoj stenki i krovi [Inflammatory-Destructive Biomarkers of Atherosclerotic Plaques Instability. Study of Arterial Wall and Blood]. Kardiologiya, 5, 37–41. [in Russian].
Paleev, F. N., Abudeeva, I. S., Moskalets, O. V., Minchenko, B. I. & Belokopytova, I. S. (2009). Nespecificheskie markery vospaleniya v prognozirovanii techeniya ishemicheskoj bolezni serdca [Nonspecific Markers of Inflammation in Prognostication of the Course of Ischemic Heart Disease]. Kardiologia, 9, pp.59-65. [in Russian].
Ridker, P., & Silvertown, J. (2008). Inflammation, C-reactive protein, and atherothrombosis. Journal of periodontology, 79(8S), 1544–1551. doi: 10.1902/jop.2008.080249.
Calabrò, P., Golia, E. & Yeh, E. (2009). CRP and the risk of atherosclerotic events. Semin Immunopathol, 31(1), 79–94. doi: 10.1007/s00281-009-0149-4.
Avanzas, P., Domínguez-Rodríguez, A., Arroyo-Espliguero, R. & Kaski, J. (2009). Neopterin and coronary artery disease. Journal of Cardiology, 54(2), 344–345. doi: 10.1016/j.jjcc.2009.07.005.
Dorzhieva, L. V., Kushkhova, D. Kh., Orlova, O. V. & Shevchenko, О. P. (2007). Klinicheskoe i diagnosticheskoe znachenie urovnya neopterina u bol'nykh s ishemicheskoj bolezn'yu serdca [Clinical and diagnostic value of neopterin levels in patients with coronary heart disease]. Kardiovaskulyarnaya terapya i profilaktika, 5, 88–89. [in Russian].
Li, Y., Zhou, C., Zhou, X., Li, L. & Hui, R. (2013). Pregnancy-associated plasma protein A predicts adverse vascular events in patients with coronary heart disease: a systematic review and meta-analysis. Archives of medical science, 9(3), 389–397. doi: 10.5114/aoms.2013.35421.
Wu, X., Liu, X., Dong, J., Wang, L., Yang, Y., Nie, S., et al. (2013). Pregnancy-Associated Plasma Protein-A as a Marker of Culprit Lesion Instability in Unstable Angina Patients: An Intravascular Ultrasound Study. Cardiology, 126(4), 244–251. doi: 10.1159/000354246.
Gaykovaya, L. B., Kukharchik, G. A., Nesterova, N. N., Vavilova, T. V., Burbello, A. T., & Shabrov, A. V. (2009). Sovremennye laboratornye markery v opredelenii prognoza pri ostrom koronarnom sindrome i monitoringe terapii [Up to date laboratory markers in assessment of the acute coronary syndrome prognosis and monitoring of therapy]. Vestnik aritmologii, 58, 52–59. [in Russian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
